Safety of fluralaner chewable tablets (BravectoTM), a novel systemic antiparasitic drug, in dogs after oral administration

Parasites and Vectors

Volumn 7, Issue 1, 2014, Pages

  Walther, Feli M ^a   Allan, Mark J ^a   Roepke, Rainer Ka ^a   Nuernberger, Martin C ^a  

^a Intervet Innovation GmbH   (Germany)

Author keywords

Bravecto ; Dog; Fluralaner; Safety

Indexed keywords

BRAVECTO; C REACTIVE PROTEIN; CORTICOTROPIN; FLURALANER; SULFADIAZINE; TRIMETHOPRIM; UNCLASSIFIED DRUG; A1443 COMPOUND; ACARICIDE; ANTIPARASITIC AGENT; INSECTICIDE; ISOXAZOLE DERIVATIVE; TABLET;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPSY; BEAGLE; CACHEXIA; CHEWABLE TABLET; CONTROLLED STUDY; DOG; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG SAFETY; FEMALE; FOOD INTAKE; LOCOMOTION; MALE; NONHUMAN; OBESITY; ORGAN WEIGHT; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; ANIMAL; BODY WEIGHT; DOSE RESPONSE; DRUG EFFECTS; EATING; HEMATOLOGY; ORAL DRUG ADMINISTRATION; ORGAN SIZE; PHYSIOLOGY; SAFETY; SINGLE BLIND PROCEDURE; TABLET; TIME;

CANIS FAMILIARIS;

ACARICIDES; ADMINISTRATION, ORAL; ANIMALS; ANTIPARASITIC AGENTS; BODY WEIGHT; C-REACTIVE PROTEIN; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; FEMALE; HEMATOLOGY; INSECTICIDES; ISOXAZOLES; MALE; ORGAN SIZE; SAFETY; SINGLE-BLIND METHOD; TABLETS; TIME FACTORS;

EID: 84898540571     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-7-87     Document Type: Article

References (8)

1. The antiparasitic isoxazoline A1443 is a potent blocker of insect ligand-gated chloride channels. Ozoe Y, Asahi M, Ozoe F, Nakahira K, Mita T, Biochem Biophys Res Commun 2010 391 744 749 10.1016/j.bbrc.2009.11.131 19944072
2. A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto™ (fluralaner) against Frontline™ (fipronil) in flea- and tick-infested dogs. Rohdich N, Roepke RKA, Zschiesche E, Parasit Vectors 2014 7 83 10.1186/1756-3305-7-83 24593931
3. Target Animal Safety for Veterinary Pharmaceutical Products Belgium 2008 URL: http://www.vichsec.org/pdf/0708/GL43-st7.doc
4. European Commission, Community register of veterinary medicinal products, Product information Bravecto, Annex 1 Summary of Product Characteristics Bruxelles 2014 URL: http://ec.europa.eu/health/documents/community-register/ html/v158.htm
5. The effect of food on the pharmacokinetics of oral fluralaner in dogs. Walther FM, Allan MJ, Roepke RKA, Nuernberger MC, Parasit Vectors 2014 7 84 10.1186/1756-3305-7-84 24598049
6. Meyer DJ, Harvey JW, Veterinary Laboratory Medicine: Interpretation and Diagnosis St. Louis: W. B. Saunders 2004
7. Pharmacokinetics of fluralaner in dogs following a single oral or intravenous administration. Kilp S, Ramirez D, Allan MJ, Roepke RKA, Nuernberger MC, Parasit Vectors 2014 7 85 10.1186/1756-3305-7-85
8. Assessment of barium impregnated polyethylene spheres (BIPS) as a measure of solid-phase gastric emptying in normal dogs-comparison to scintigraphy. Lester NV, Roberts GD, Newell SM, Graham JP, Hartless CS, Vet Radiol Ultrasound 1999 40 465 471 10.1111/j.1740-8261.1999.tb00376.x 10528839 (Pubitemid 129613494)